secwatch / observer
8-K filed March 20, 2025, 7:59 PM ET ticker OCEA CIK 0001869974
regulatory confidence high sentiment negative materiality 0.90

Ocean Biomedical, Inc. (OCEA): Nasdaq/NYSE listing notice — Ocean Biomedical receives Nasdaq delisting notice for low-priced stock rule; bid price <=$0.10 for 10 days

Ocean Biomedical, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Ocean Biomedical, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii), 5550(a)(2)).

Exchange
nasdaq
Notice
noncompliance notice
Deficiency
minimum bid price
Rules
5810(c)(3)(A)(iii), 5550(a)(2)
Exact text from the filing
March 14, 2025, the Company received a notice from Nasdaq that Staff has determined that as of March 13, 2025, the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days. Accordingly, the Company is subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”). Accordingly, this matter serves as an additional basis for delisting the Company’s securities from The Nasdaq Stock Market 1 . Nasdaq Hearings Panel (the “Panel”) will consider this matter in their decision regarding the Company’s continued listing on
View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Ocean Biomedical, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-25-011046
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.